Novavax posts higher-than-expected revenue, says prepared to further cut costs
(Reuters) -COVID-19 vaccine maker Novavax on Thursday reported higher-than-expected revenue for the third quarter, boosted by U.S. government grants to
2023-11-09 21:26
US FDA authorizes Novavax's updated COVID shot, shares rise
By Sriparna Roy and Michael Erman (Reuters) -The U.S. Food and Drug Administration said on Tuesday it authorized an updated
2023-10-05 02:50